Monthly
US$200
Billed every month
Lactulose Oral Solution(乳果糖口服溶液)
Companies, stages and changes, with each record available on this page.
Last 90 days: Accepted: 15 applicationsNo longer listed under review: 4 applicationsSupplement delivery: 6 applications
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Company names, approval identifiers and strengths are retained as recorded in the Chinese sources. Category labels include the original wording for verification.
Catalogue holders1View records ↓
Under-review filings36View records ↓
This year’s generic filers9View records ↓
NHSA approval numbers112View records ↓
API companies with A status1View records ↓
Chemical-drug catalogue
Loaded records: 1 holders; 0 in the quality-and-efficacy consistency-evaluation category, and 0 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Abbott Healthcare Products B.V. | Abbott Biologicals B.V. | H20171057 | 1996/06/25 | 667mg/ml | Imported originator drug (进口原研药品) | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 112 distinct approval numbers and 67 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| 湖南千金湘江药业股份有限公司 | 国药准字H20264429 | 200ml:133.4g | Category B (乙) | XA06ADR050X001010104960 | NHSA |
| 江西海尔思药业股份有限公司 | 国药准字H20263062 | 15ml:10g | Category B (乙) | XA06ADR050X001010105291 | NHSA |
| 江西盛翔制药有限公司 | 国药准字H20265144 | 15ml:10g | Category B (乙) | XA06ADR050X001010105355 | NHSA |
| 浙江远力健药业有限责任公司 | 国药准字H20263202 | 15ml:10g | Category B (乙) | XA06ADR050X001010109207 | NHSA |
| 南京海纳制药有限公司 | 国药准字H20263084 | 15ml:10g | Category B (乙) | XA06ADR050X001010180537 | NHSA |
| 山东辰欣佛都药业股份有限公司 | 国药准字H20264746 | 15ml:10g | Category B (乙) | XA06ADR050X001010183191 | NHSA |
| 翎耀生物科技(上海)有限公司 | 国药准字H20265379 | 200ml:133.4g | Category B (乙) | XA06ADR050X001010183356 | NHSA |
| 江苏广承药业有限公司 | 国药准字H20263308 | 100ml :66.7g | Category B (乙) | XA06ADR050X001010183611 | NHSA |
| 广州琥瑞医药科技发展有限公司 | 国药准字H20263599 | 15ml:10g | Category B (乙) | XA06ADR050X001010183642 | NHSA |
| 河南合智医药科技有限公司 | 国药准字H20264134 | 200ml:133.4g | Category B (乙) | XA06ADR050X001010183926 | NHSA |
| 西洲医药科技(浙江)有限公司 | 国药准字H20263762 | 15ml:10g | Category B (乙) | XA06ADR050X001010184209 | NHSA |
| 福建省融恒医药有限公司 | 国药准字H20265345 | 100ml:66.7g | Category B (乙) | XA06ADR050X001010184977 | NHSA |
| 江西盛翔制药有限公司 | 国药准字H20265144 | 15ml:10g | Category B (乙) | XA06ADR050X001010205355 | NHSA |
| 浙江远力健药业有限责任公司 | 国药准字H20263202 | 15ml:10g | Category B (乙) | XA06ADR050X001010209207 | NHSA |
| 山东辰欣佛都药业股份有限公司 | 国药准字H20264746 | 15ml:10g | Category B (乙) | XA06ADR050X001010283191 | NHSA |
| 西洲医药科技(浙江)有限公司 | 国药准字H20263762 | 15ml:10g | Category B (乙) | XA06ADR050X001010284209 | NHSA |
| 江西盛翔制药有限公司 | 国药准字H20265144 | 15ml:10g | Category B (乙) | XA06ADR050X001010305355 | NHSA |
| 山东辰欣佛都药业股份有限公司 | 国药准字H20264746 | 15ml:10g | Category B (乙) | XA06ADR050X001010383191 | NHSA |
| 江西盛翔制药有限公司 | 国药准字H20265144 | 15ml:10g | Category B (乙) | XA06ADR050X001010405355 | NHSA |
| 山东辰欣佛都药业股份有限公司 | 国药准字H20264746 | 15ml:10g | Category B (乙) | XA06ADR050X001010483191 | NHSA |
| 江西盛翔制药有限公司 | 国药准字H20265144 | 15ml:10g | Category B (乙) | XA06ADR050X001010505355 | NHSA |
| 山东辰欣佛都药业股份有限公司 | 国药准字H20264746 | 15ml:10g | Category B (乙) | XA06ADR050X001010583191 | NHSA |
| 江西盛翔制药有限公司 | 国药准字H20265144 | 15ml:10g | Category B (乙) | XA06ADR050X001010605355 | NHSA |
| 山东辰欣佛都药业股份有限公司 | 国药准字H20264746 | 15ml:10g | Category B (乙) | XA06ADR050X001010683191 | NHSA |
| 江西盛翔制药有限公司 | 国药准字H20265144 | 15ml:10g | Category B (乙) | XA06ADR050X001010705355 | NHSA |
| 山东辰欣佛都药业股份有限公司 | 国药准字H20264746 | 15ml:10g | Category B (乙) | XA06ADR050X001010783191 | NHSA |
| 江西盛翔制药有限公司 | 国药准字H20265144 | 15ml:10g | Category B (乙) | XA06ADR050X001010805355 | NHSA |
| 山东辰欣佛都药业股份有限公司 | 国药准字H20264746 | 15ml:10g | Category B (乙) | XA06ADR050X001010883191 | NHSA |
| 山东辰欣佛都药业股份有限公司 | 国药准字H20264746 | 15ml:10g | Category B (乙) | XA06ADR050X001010983191 | NHSA |
| 山东辰欣佛都药业股份有限公司 | 国药准字H20264746 | 15ml:10g | Category B (乙) | XA06ADR050X001011083191 | NHSA |
| 山东辰欣佛都药业股份有限公司 | 国药准字H20264746 | 15ml:10g | Category B (乙) | XA06ADR050X001011183191 | NHSA |
| 江西海尔思药业股份有限公司 | 国药准字H20263063 | 200ml:133.4g | Category B (乙) | XA06ADR050X001020105291 | NHSA |
| 江西盛翔制药有限公司 | 国药准字H20265145 | 200ml:133.4g | Category B (乙) | XA06ADR050X001020105355 | NHSA |
| 南京海纳制药有限公司 | 国药准字H20263084 | 15ml:10g | Category B (乙) | XA06ADR050X001020180537 | NHSA |
| 翎耀生物科技(上海)有限公司 | 国药准字H20265378 | 15ml: 10g | Category B (乙) | XA06ADR050X001020183356 | NHSA |
| 重庆和平制药有限公司 | 国药准字H20263307 | 15ml:10g | Category B (乙) | XA06ADR050X001030101001 | NHSA |
| 陕西兴邦药业有限公司 | 国药准字H20264284 | 200ml:133.4g | Category B (乙) | XA06ADR050X001030102471 | NHSA |
| 安徽四环科宝制药有限公司 | 国药准字H20263102 | 5ml:3.3g | Category B (乙) | XA06ADR050X001030183595 | NHSA |
| 重庆和平制药有限公司 | 国药准字H20263307 | 15ml:10g | Category B (乙) | XA06ADR050X001030201001 | NHSA |
| 安徽四环科宝制药有限公司 | 国药准字H20263102 | 5ml:3.3g | Category B (乙) | XA06ADR050X001030283595 | NHSA |
| 安徽四环科宝制药有限公司 | 国药准字H20263102 | 5ml:3.3g | Category B (乙) | XA06ADR050X001030383595 | NHSA |
| 安徽四环科宝制药有限公司 | 国药准字H20263102 | 5ml:3.3g | Category B (乙) | XA06ADR050X001030483595 | NHSA |
| 陕西兴邦药业有限公司 | 国药准字H20264285 | 5ml:3.3g | Category B (乙) | XA06ADR050X001040102471 | NHSA |
| 陕西兴邦药业有限公司 | 国药准字H20264286 | 100ml:66.7g | Category B (乙) | XA06ADR050X001050102471 | NHSA |
| 陕西兴邦药业有限公司 | 国药准字H20264287 | 15ml:10g | Category B (乙) | XA06ADR050X001060102471 | NHSA |
| 福元药业有限公司 | 国药准字H20269132 | 100ml:66.7g | Category B (乙) | XA06ADR050X001060180651 | NHSA |
| 重庆和平制药有限公司 | 国药准字H20256361 | 200ml:133.4g | Category B (乙) | XA06ADR050X001010101001 | NHSA |
| 美罗药业股份有限公司 | 国药准字H20258288 | 200ml:133.4g | Category B (乙) | XA06ADR050X001010101122 | NHSA |
| 江苏万高药业股份有限公司 | 国药准字H20256407 | 15ml:10g | Category B (乙) | XA06ADR050X001010101503 | NHSA |
| 云鹏医药集团有限公司 | 国药准字H20253657 | 15ml:10g | Category B (乙) | XA06ADR050X001010102968 | NHSA |
| 哈药集团中药二厂 | 国药准字H20253805 | 15mL:10g | Category B (乙) | XA06ADR050X001010103714 | NHSA |
| 山东京卫制药有限公司 | 国药准字H20253157 | 15ml:10g | Category B (乙) | XA06ADR050X001010104111 | NHSA |
| 国药控股星鲨制药(厦门)有限公司 | 国药准字H20255372 | 15ml:10g | Category B (乙) | XA06ADR050X001010104873 | NHSA |
| 广西维威制药有限公司 | 国药准字H20255429 | 15ml:10g | Category B (乙) | XA06ADR050X001010105237 | NHSA |
| 成都倍特得诺药业有限公司 | 国药准字H20254757 | 5ml:3.3g | Category B (乙) | XA06ADR050X001010182338 | NHSA |
| 济南康桥医药科技有限公司 | 国药准字H20253347 | 200ml:133.4g | Category B (乙) | XA06ADR050X001010183056 | NHSA |
| 青岛格恩制药有限公司 | 国药准字H20253484 | 15ml:10g | Category B (乙) | XA06ADR050X001010183584 | NHSA |
| 安徽四环科宝制药有限公司 | 国药准字H20255546 | 15ml:10g | Category B (乙) | XA06ADR050X001010183595 | NHSA |
| 重庆健能药业集团有限公司 | 国药准字H20253369 | 100ml:66.7g | Category B (乙) | XA06ADR050X001010183692 | NHSA |
| 乐福思健康产业股份公司 | 国药准字H20254718 | 15ml:10g | Category B (乙) | XA06ADR050X001010183955 | NHSA |
| 国药集团致君(深圳)坪山制药有限公司 | 国药准字H20253075 | 15ml:10g | Category B (乙) | XA06ADR050X001010184482 | NHSA |
| 湖北美思创药业有限公司 | 国药准字H20253366 | 100ml:66.7g | Category B (乙) | XA06ADR050X001010184577 | NHSA |
| 北京韩美生物科技有限公司 | 国药准字H20253514 | 100ml:66.7g | Category B (乙) | XA06ADR050X001010184761 | NHSA |
| 重庆市义力医药科技有限公司 | 国药准字H20254719 | 100ml:66.7g | Category B (乙) | XA06ADR050X001010184778 | NHSA |
| 湖南及正医药科技有限公司 | 国药准字H20255714 | 15ml:10g | Category B (乙) | XA06ADR050X001010184994 | NHSA |
| 江西远超医药科技有限公司 | 国药准字H20255383 | 15ml:10g | Category B (乙) | XA06ADR050X001010185010 | NHSA |
| 成都克莱蒙医药科技有限公司 | 国药准字H20255718 | 200ml:133.4g | Category B (乙) | XA06ADR050X001010185240 | NHSA |
| 江苏万高药业股份有限公司 | 国药准字H20256407 | 15ml:10g | Category B (乙) | XA06ADR050X001010201503 | NHSA |
| 云鹏医药集团有限公司 | 国药准字H20253657 | 15ml:10g | Category B (乙) | XA06ADR050X001010202968 | NHSA |
| 山东京卫制药有限公司 | 国药准字H20253157 | 15ml:10g | Category B (乙) | XA06ADR050X001010204111 | NHSA |
| 广西维威制药有限公司 | 国药准字H20255429 | 15ml:10g | Category B (乙) | XA06ADR050X001010205237 | NHSA |
| 成都倍特得诺药业有限公司 | 国药准字H20254757 | 5ml:3.3g | Category B (乙) | XA06ADR050X001010282338 | NHSA |
| 安徽四环科宝制药有限公司 | 国药准字H20255546 | 15ml:10g | Category B (乙) | XA06ADR050X001010283595 | NHSA |
| 乐福思健康产业股份公司 | 国药准字H20254718 | 15ml:10g | Category B (乙) | XA06ADR050X001010283955 | NHSA |
| 国药集团致君(深圳)坪山制药有限公司 | 国药准字H20253075 | 15ml:10g | Category B (乙) | XA06ADR050X001010284482 | NHSA |
| 江苏万高药业股份有限公司 | 国药准字H20256407 | 15ml:10g | Category B (乙) | XA06ADR050X001010301503 | NHSA |
| 云鹏医药集团有限公司 | 国药准字H20253657 | 15ml:10g | Category B (乙) | XA06ADR050X001010302968 | NHSA |
| 安徽四环科宝制药有限公司 | 国药准字H20255546 | 15ml:10g | Category B (乙) | XA06ADR050X001010383595 | NHSA |
| 安徽四环科宝制药有限公司 | 国药准字H20255546 | 15ml:10g | Category B (乙) | XA06ADR050X001010483595 | NHSA |
| 重庆和平制药有限公司 | 国药准字H20256360 | 100ml:66.7g | Category B (乙) | XA06ADR050X001020101001 | NHSA |
| 美罗药业股份有限公司 | 国药准字H20253985 | 100ml: 66.7g | Category B (乙) | XA06ADR050X001020101122 | NHSA |
| 江苏万高药业股份有限公司 | 国药准字H20256408 | 200ml:133.4g | Category B (乙) | XA06ADR050X001020101503 | NHSA |
| 哈药集团中药二厂 | 国药准字H20253805 | 15mL:10g | Category B (乙) | XA06ADR050X001020103714 | NHSA |
| 国药控股星鲨制药(厦门)有限公司 | 国药准字H20255373 | 200ml:133.4g | Category B (乙) | XA06ADR050X001020104873 | NHSA |
| 广西维威制药有限公司 | 国药准字H20255430 | 200ml:133.4g | Category B (乙) | XA06ADR050X001020105237 | NHSA |
| 成都倍特得诺药业有限公司 | 国药准字H20254758 | 200ml:133.4g | Category B (乙) | XA06ADR050X001020182338 | NHSA |
| 济南康桥医药科技有限公司 | 国药准字H20253348 | 100ml:66.7g | Category B (乙) | XA06ADR050X001020183056 | NHSA |
| 安徽四环科宝制药有限公司 | 国药准字H20255546 | 15ml:10g | Category B (乙) | XA06ADR050X001020183595 | NHSA |
| 重庆健能药业集团有限公司 | 国药准字H20253370 | 15ml:10g | Category B (乙) | XA06ADR050X001020183692 | NHSA |
| 北京韩美生物科技有限公司 | 国药准字H20254035 | 15ml:10g | Category B (乙) | XA06ADR050X001020184761 | NHSA |
| 重庆市义力医药科技有限公司 | 国药准字H20254720 | 200ml:133.4g | Category B (乙) | XA06ADR050X001020184778 | NHSA |
| 湖南及正医药科技有限公司 | 国药准字H20255715 | 200ml:133.4g | Category B (乙) | XA06ADR050X001020184994 | NHSA |
| 江西远超医药科技有限公司 | 国药准字H20255382 | 200ml:133.4g | Category B (乙) | XA06ADR050X001020185010 | NHSA |
| 成都克莱蒙医药科技有限公司 | 国药准字H20255719 | 15ml:10g | Category B (乙) | XA06ADR050X001020185240 | NHSA |
| 美罗药业股份有限公司 | 国药准字H20258287 | 5ml:3.3g | Category B (乙) | XA06ADR050X001030101122 | NHSA |
| 北京诚济制药股份有限公司 | 国药准字H20258290 | 60ml:40.02g | Category B (乙) | XA06ADR050X001030182209 | NHSA |
| 济南康桥医药科技有限公司 | 国药准字H20253349 | 15ml:10g | Category B (乙) | XA06ADR050X001030183056 | NHSA |
| 湖南及正医药科技有限公司 | 国药准字H20255714 | 15ml:10g | Category B (乙) | XA06ADR050X001030184994 | NHSA |
| 济南康桥医药科技有限公司 | 国药准字H20253349 | 15ml:10g | Category B (乙) | XA06ADR050X001030283056 | NHSA |
| 美罗药业股份有限公司 | 国药准字H20258286 | 15ml:10g | Category B (乙) | XA06ADR050X001040101122 | NHSA |
| 北京诚济制药股份有限公司 | 国药准字H20258291 | 100ml:66.7g | Category B (乙) | XA06ADR050X001040182209 | NHSA |
| 福元药业有限公司 | 国药准字H20253168 | 200ml:133.4g | Category B (乙) | XA06ADR050X001050180651 | NHSA |
| 北京韩美药品有限公司 | 国药准字H20065730 | 100ml:66.7g | Category B (乙) | XA06ADR050X001010100041 | NHSA |
| 大连美罗中药厂有限公司 | 国药准字H20093299 | 10ml:5g | Category B (乙) | XA06ADR050X001010101123 | NHSA |
| 丹东康复制药有限公司 | 国药准字H10890057 | 50% | Category B (乙) | XA06ADR050X001010101150 | NHSA |
| 健民药业集团股份有限公司 | 国药准字H20244664 | 200ml:133.4g | Category B (乙) | XA06ADR050X001010101946 | NHSA |
| 四川健能制药有限公司 | 国药准字H20103621 | 60ml:40.02g | Category B (乙) | XA06ADR050X001010102166 | NHSA |
| 陕西汉唐制药有限公司 | 国药准字H10890034 | 100ml:50g | Category B (乙) | XA06ADR050X001010102471 | NHSA |
| 石药银湖制药有限公司 | 国药准字H20249423 | 15ml:10g | Category B (乙) | XA06ADR050X001010102964 | NHSA |
| 黑龙江中桂制药有限公司 | 国药准字H20249558 | 15ml:10g | Category B (乙) | XA06ADR050X001010103804 | NHSA |
| 青岛黄海制药有限责任公司 | 国药准字H20249749 | 15ml:10g | Category B (乙) | XA06ADR050X001010104043 | NHSA |
| 莱阳市江波制药有限责任公司 | 国药准字H20074009 | 10ml:5g | Category B (乙) | XA06ADR050X001010104201 | NHSA |
| 北京麦康药业有限公司 | 国药准字H20234275 | 200ml:133.4g | Category B (乙) | XA06ADR050X001010104948 | NHSA |
| 湖南科伦制药有限公司 | 国药准字H20093523 | 100ml:66.7g | Category B (乙) | XA06ADR050X001010105006 | NHSA |
| 江右制药(常德)有限公司 | 国药准字H20249250 | 15ml:10g | Category B (乙) | XA06ADR050X001010105031 | NHSA |
| 海南斯达制药有限公司 | 国药准字H20249475 | 200ml:133.4g | Category B (乙) | XA06ADR050X001010105816 | NHSA |
| Fresenius Kabi Austria GmbH | H20160470 | 100ml:67g | Category B (乙) | XA06ADR050X001010178433 | NHSA |
| Abbott B.V. | 国药准字HJ20171057 | 667mg/ml | Category B (乙) | XA06ADR050X001010178890 | NHSA |
| 北京麦康药业有限公司 | 国药准字H20234273 | 15ml:10g | Category B (乙) | XA06ADR050X001010180528 | NHSA |
| 宿州亿帆药业有限公司 | 国药准字J20170046 | 100ml: 67g | Category B (乙) | XA06ADR050X001010180637 | NHSA |
| 福元药业有限公司 | 国药准字H20243601 | 15ml:10g | Category B (乙) | XA06ADR050X001010180651 | NHSA |
| 四川德峰药业有限公司 | 国药准字H20223553 | 667mg/mL(5ml:3.3g、15ml:10g、100ml:66.7g、200ml:133.4g) | Category B (乙) | XA06ADR050X001010181575 | NHSA |
| 北京诚济制药股份有限公司 | 国药准字H20233728 | 667mg/ml(15ml:10g、200ml:133.4g) | Category B (乙) | XA06ADR050X001010182209 | NHSA |
| 海南万玮制药有限公司 | 国药准字H20249253 | 15ml:10g | Category B (乙) | XA06ADR050X001010182249 | NHSA |
| 保定爱晖药业有限公司 | 国药准字H20249742 | 200ml:133.4g | Category B (乙) | XA06ADR050X001010182314 | NHSA |
| 苏州二叶制药有限公司 | 国药准字H20249347 | 15ml:10g | Category B (乙) | XA06ADR050X001010183242 | NHSA |
| 山东新华制药股份有限公司 | 国药准字H20243526 | 100ml:66.7g | Category B (乙) | XA06ADR050X001010183644 | NHSA |
| 山东新华制药股份有限公司 | 国药准字H20249342 | 15ml:10g | Category B (乙) | XA06ADR050X001010183719 | NHSA |
| 江苏悦兴药业有限公司 | 国药准字H20249283 | 200ml:133.4g | Category B (乙) | XA06ADR050X001010183775 | NHSA |
| 海南美康达药业有限公司 | 国药准字H20243713 | 15ml:10g | Category B (乙) | XA06ADR050X001010183920 | NHSA |
| 重庆迈川医药科技有限公司 | 国药准字H20249795 | 15ml:10g | Category B (乙) | XA06ADR050X001010184196 | NHSA |
| 华润江中药业股份有限公司 | 国药准字H20244227 | 15ml:10g | Category B (乙) | XA06ADR050X001010184211 | NHSA |
| 浙江高跖医药科技股份有限公司 | 国药准字H20244623 | 15ml:10g | Category B (乙) | XA06ADR050X001010184221 | NHSA |
| 江西丹康制药有限公司 | 国药准字H20244825 | 200ml:133.4g | Category B (乙) | XA06ADR050X001010184227 | NHSA |
| 华萃国际生物科技(广东)有限公司 | 国药准字H20249304 | 100ml:66.7g | Category B (乙) | XA06ADR050X001010184487 | NHSA |
| 北京富新安康医药科技有限公司 | 国药准字H20244690 | 15ml:10g | Category B (乙) | XA06ADR050X001010184745 | NHSA |
| 大连美罗中药厂有限公司 | 国药准字H20093299 | 10ml:5g | Category B (乙) | XA06ADR050X001010201123 | NHSA |
| 丹东康复制药有限公司 | 国药准字H10890057 | 50% | Category B (乙) | XA06ADR050X001010201150 | NHSA |
| 黑龙江中桂制药有限公司 | 国药准字H20249558 | 15ml:10g | Category B (乙) | XA06ADR050X001010203804 | NHSA |
| 青岛黄海制药有限责任公司 | 国药准字H20249749 | 15ml:10g | Category B (乙) | XA06ADR050X001010204043 | NHSA |
| 江右制药(常德)有限公司 | 国药准字H20249250 | 15ml:10g | Category B (乙) | XA06ADR050X001010205031 | NHSA |
| 云南康健善美制药有限公司 | 国药准字H53020078 | 100ml:50g | Category B (乙) | XA06ADR050X001010205681 | NHSA |
| 北京麦康药业有限公司 | 国药准字H20234273 | 15ml:10g | Category B (乙) | XA06ADR050X001010280528 | NHSA |
| 福元药业有限公司 | 国药准字H20243601 | 15ml:10g | Category B (乙) | XA06ADR050X001010280651 | NHSA |
| 四川德峰药业有限公司 | 国药准字H20223553 | 667mg/mL(5ml:3.3g、15ml:10g、100ml:66.7g、200ml:133.4g) | Category B (乙) | XA06ADR050X001010281575 | NHSA |
| 北京诚济制药股份有限公司 | 国药准字H20233728 | 667mg/ml(15ml:10g、200ml:133.4g) | Category B (乙) | XA06ADR050X001010282209 | NHSA |
| 海南万玮制药有限公司 | 国药准字H20249253 | 15ml:10g | Category B (乙) | XA06ADR050X001010282249 | NHSA |
| 苏州二叶制药有限公司 | 国药准字H20249347 | 15ml:10g | Category B (乙) | XA06ADR050X001010283242 | NHSA |
| 山东新华制药股份有限公司 | 国药准字H20249342 | 15ml:10g | Category B (乙) | XA06ADR050X001010283719 | NHSA |
| 重庆迈川医药科技有限公司 | 国药准字H20249795 | 15ml:10g | Category B (乙) | XA06ADR050X001010284196 | NHSA |
| 浙江高跖医药科技股份有限公司 | 国药准字H20244623 | 15ml:10g | Category B (乙) | XA06ADR050X001010284221 | NHSA |
| 北京富新安康医药科技有限公司 | 国药准字H20244690 | 15ml:10g | Category B (乙) | XA06ADR050X001010284745 | NHSA |
| 大连美罗中药厂有限公司 | 国药准字H20093299 | 10ml:5g | Category B (乙) | XA06ADR050X001010301123 | NHSA |
| 丹东康复制药有限公司 | 国药准字H10890057 | 50% | Category B (乙) | XA06ADR050X001010301150 | NHSA |
| 青岛黄海制药有限责任公司 | 国药准字H20249749 | 15ml:10g | Category B (乙) | XA06ADR050X001010304043 | NHSA |
| 江右制药(常德)有限公司 | 国药准字H20249250 | 15ml:10g | Category B (乙) | XA06ADR050X001010305031 | NHSA |
| 北京麦康药业有限公司 | 国药准字H20234273 | 15ml:10g | Category B (乙) | XA06ADR050X001010380528 | NHSA |
| 福元药业有限公司 | 国药准字H20243601 | 15ml:10g | Category B (乙) | XA06ADR050X001010380651 | NHSA |
| 四川德峰药业有限公司 | 国药准字H20223553 | 667mg/mL(5ml:3.3g、15ml:10g、100ml:66.7g、200ml:133.4g) | Category B (乙) | XA06ADR050X001010381575 | NHSA |
| 北京诚济制药股份有限公司 | 国药准字H20233728 | 667mg/ml(15ml:10g、200ml:133.4g) | Category B (乙) | XA06ADR050X001010382209 | NHSA |
| 海南万玮制药有限公司 | 国药准字H20249253 | 15ml:10g | Category B (乙) | XA06ADR050X001010382249 | NHSA |
| 苏州二叶制药有限公司 | 国药准字H20249347 | 15ml:10g | Category B (乙) | XA06ADR050X001010383242 | NHSA |
| 北京富新安康医药科技有限公司 | 国药准字H20244690 | 15ml:10g | Category B (乙) | XA06ADR050X001010384745 | NHSA |
| 大连美罗中药厂有限公司 | 国药准字H20093299 | 10ml:5g | Category B (乙) | XA06ADR050X001010401123 | NHSA |
| 丹东康复制药有限公司 | 国药准字H10890057 | 50% | Category B (乙) | XA06ADR050X001010401150 | NHSA |
| 青岛黄海制药有限责任公司 | 国药准字H20249749 | 15ml:10g | Category B (乙) | XA06ADR050X001010404043 | NHSA |
| 江右制药(常德)有限公司 | 国药准字H20249250 | 15ml:10g | Category B (乙) | XA06ADR050X001010405031 | NHSA |
| 北京麦康药业有限公司 | 国药准字H20234273 | 15ml:10g | Category B (乙) | XA06ADR050X001010480528 | NHSA |
| 四川德峰药业有限公司 | 国药准字H20223553 | 667mg/mL(5ml:3.3g、15ml:10g、100ml:66.7g、200ml:133.4g) | Category B (乙) | XA06ADR050X001010481575 | NHSA |
| 北京诚济制药股份有限公司 | 国药准字H20233728 | 667mg/ml(15ml:10g、200ml:133.4g) | Category B (乙) | XA06ADR050X001010482209 | NHSA |
| 海南万玮制药有限公司 | 国药准字H20249253 | 15ml:10g | Category B (乙) | XA06ADR050X001010482249 | NHSA |
| 苏州二叶制药有限公司 | 国药准字H20249347 | 15ml:10g | Category B (乙) | XA06ADR050X001010483242 | NHSA |
| 大连美罗中药厂有限公司 | 国药准字H20093299 | 10ml:5g | Category B (乙) | XA06ADR050X001010501123 | NHSA |
| 青岛黄海制药有限责任公司 | 国药准字H20249749 | 15ml:10g | Category B (乙) | XA06ADR050X001010504043 | NHSA |
| 江右制药(常德)有限公司 | 国药准字H20249250 | 15ml:10g | Category B (乙) | XA06ADR050X001010505031 | NHSA |
| 北京麦康药业有限公司 | 国药准字H20234273 | 15ml:10g | Category B (乙) | XA06ADR050X001010580528 | NHSA |
| 四川德峰药业有限公司 | 国药准字H20223553 | 667mg/mL(5ml:3.3g、15ml:10g、100ml:66.7g、200ml:133.4g) | Category B (乙) | XA06ADR050X001010581575 | NHSA |
| 北京诚济制药股份有限公司 | 国药准字H20233728 | 667mg/ml(15ml:10g、200ml:133.4g) | Category B (乙) | XA06ADR050X001010582209 | NHSA |
| 海南万玮制药有限公司 | 国药准字H20249253 | 15ml:10g | Category B (乙) | XA06ADR050X001010582249 | NHSA |
| 苏州二叶制药有限公司 | 国药准字H20249347 | 15ml:10g | Category B (乙) | XA06ADR050X001010583242 | NHSA |
| 大连美罗中药厂有限公司 | 国药准字H20093299 | 10ml:5g | Category B (乙) | XA06ADR050X001010601123 | NHSA |
| 青岛黄海制药有限责任公司 | 国药准字H20249749 | 15ml:10g | Category B (乙) | XA06ADR050X001010604043 | NHSA |
| 北京麦康药业有限公司 | 国药准字H20234273 | 15ml:10g | Category B (乙) | XA06ADR050X001010680528 | NHSA |
| 四川德峰药业有限公司 | 国药准字H20223553 | 667mg/mL(5ml:3.3g、15ml:10g、100ml:66.7g、200ml:133.4g) | Category B (乙) | XA06ADR050X001010681575 | NHSA |
| 海南万玮制药有限公司 | 国药准字H20249253 | 15ml:10g | Category B (乙) | XA06ADR050X001010682249 | NHSA |
| 苏州二叶制药有限公司 | 国药准字H20249347 | 15ml:10g | Category B (乙) | XA06ADR050X001010683242 | NHSA |
| 大连美罗中药厂有限公司 | 国药准字H20093299 | 10ml:5g | Category B (乙) | XA06ADR050X001010701123 | NHSA |
| 北京麦康药业有限公司 | 国药准字H20234273 | 15ml:10g | Category B (乙) | XA06ADR050X001010780528 | NHSA |
| 北京韩美药品有限公司 | 国药准字H20065730 | 100ml:66.7g | Category B (乙) | XA06ADR050X001020100041 | NHSA |
| 大连美罗中药厂有限公司 | 国药准字H20093300 | 100ml:50g | Category B (乙) | XA06ADR050X001020101123 | NHSA |
| 丹东康复制药有限公司 | 国药准字H10890057 | 50% | Category B (乙) | XA06ADR050X001020101150 | NHSA |
| 四川健能制药有限公司 | 国药准字H20103621 | 60ml:40.02g | Category B (乙) | XA06ADR050X001020102166 | NHSA |
| 陕西汉唐制药有限公司 | 国药准字H10890034 | 100ml:50g | Category B (乙) | XA06ADR050X001020102471 | NHSA |
| 青岛黄海制药有限责任公司 | 国药准字H20249750 | 100ml:66.7g | Category B (乙) | XA06ADR050X001020104043 | NHSA |
| 莱阳市江波制药有限责任公司 | 国药准字H20074010 | 100ml:50g | Category B (乙) | XA06ADR050X001020104201 | NHSA |
| 湖南科伦制药有限公司 | 国药准字H20093524 | 250ml:166.8g | Category B (乙) | XA06ADR050X001020105006 | NHSA |
| Fresenius Kabi Austria GmbH | H20160470 | 100ml:67g | Category B (乙) | XA06ADR050X001020178433 | NHSA |
| Abbott B.V. | 国药准字HJ20171057 | 667mg/ml | Category B (乙) | XA06ADR050X001020178890 | NHSA |
| 北京麦康药业有限公司 | 国药准字H20234274 | 100ml:66.7g | Category B (乙) | XA06ADR050X001020180528 | NHSA |
| 福元药业有限公司 | 国药准字H20243601 | 15ml:10g | Category B (乙) | XA06ADR050X001020180651 | NHSA |
| 四川德峰药业有限公司 | 国药准字H20223553 | 667mg/mL(5ml:3.3g、15ml:10g、100ml:66.7g、200ml:133.4g) | Category B (乙) | XA06ADR050X001020181575 | NHSA |
| 北京诚济制药股份有限公司 | 国药准字H20233728 | 667mg/ml(15ml:10g、200ml:133.4g) | Category B (乙) | XA06ADR050X001020182209 | NHSA |
| 苏州二叶制药有限公司 | 国药准字H20249348 | 200ml:133.4g | Category B (乙) | XA06ADR050X001020183242 | NHSA |
| 海南美康达药业有限公司 | 国药准字H20243714 | 100ml:66.7g | Category B (乙) | XA06ADR050X001020183920 | NHSA |
| 重庆迈川医药科技有限公司 | 国药准字H20249796 | 5ml:3.3g | Category B (乙) | XA06ADR050X001020184196 | NHSA |
| 华润江中药业股份有限公司 | 国药准字H20244228 | 200ml:133.4g | Category B (乙) | XA06ADR050X001020184211 | NHSA |
| 浙江高跖医药科技股份有限公司 | 国药准字H20244624 | 200ml:133.4g | Category B (乙) | XA06ADR050X001020184221 | NHSA |
| 江西丹康制药有限公司 | 国药准字H20244824 | 15ml:10g | Category B (乙) | XA06ADR050X001020184227 | NHSA |
| 北京富新安康医药科技有限公司 | 国药准字H20244690 | 15ml:10g | Category B (乙) | XA06ADR050X001020184745 | NHSA |
| 四川德峰药业有限公司 | 国药准字H20223553 | 667mg/mL(5ml:3.3g、15ml:10g、100ml:66.7g、200ml:133.4g) | Category B (乙) | XA06ADR050X001020281575 | NHSA |
| 江西丹康制药有限公司 | 国药准字H20244824 | 15ml:10g | Category B (乙) | XA06ADR050X001020284227 | NHSA |
| 北京富新安康医药科技有限公司 | 国药准字H20244690 | 15ml:10g | Category B (乙) | XA06ADR050X001020284745 | NHSA |
| 江西丹康制药有限公司 | 国药准字H20244824 | 15ml:10g | Category B (乙) | XA06ADR050X001020384227 | NHSA |
| 北京富新安康医药科技有限公司 | 国药准字H20244690 | 15ml:10g | Category B (乙) | XA06ADR050X001020384745 | NHSA |
| 江西丹康制药有限公司 | 国药准字H20244824 | 15ml:10g | Category B (乙) | XA06ADR050X001020484227 | NHSA |
| 北京富新安康医药科技有限公司 | 国药准字H20244690 | 15ml:10g | Category B (乙) | XA06ADR050X001020484745 | NHSA |
| 北京韩美药品有限公司 | 国药准字H20065730 | 100ml:66.7g | Category B (乙) | XA06ADR050X001030100041 | NHSA |
| 大连美罗中药厂有限公司 | 国药准字H20093299 | 10ml:5g | Category B (乙) | XA06ADR050X001030101123 | NHSA |
| 四川健能制药有限公司 | 国药准字H20103621 | 60ml:40.02g | Category B (乙) | XA06ADR050X001030102166 | NHSA |
| 莱阳市江波制药有限责任公司 | 国药准字H20074009 | 10ml:5g | Category B (乙) | XA06ADR050X001030104201 | NHSA |
| Fresenius Kabi Austria GmbH | 国药准字HJ20170152 | 15ml:10g | Category B (乙) | XA06ADR050X001030178433 | NHSA |
| Abbott B.V. | 国药准字HJ20171057 | 667mg/ml | Category B (乙) | XA06ADR050X001030178890 | NHSA |
| 北京麦康药业有限公司 | 国药准字H20234273 | 15ml:10g | Category B (乙) | XA06ADR050X001030180528 | NHSA |
| 福元药业有限公司 | 国药准字H20243601 | 15ml:10g | Category B (乙) | XA06ADR050X001030180651 | NHSA |
| 四川德峰药业有限公司 | 国药准字H20223553 | 667mg/mL(5ml:3.3g、15ml:10g、100ml:66.7g、200ml:133.4g) | Category B (乙) | XA06ADR050X001030181575 | NHSA |
| 华润江中药业股份有限公司 | 国药准字H20244227 | 15ml:10g | Category B (乙) | XA06ADR050X001030184211 | NHSA |
| 江西丹康制药有限公司 | 国药准字H20244824 | 15ml:10g | Category B (乙) | XA06ADR050X001030184227 | NHSA |
| 大连美罗中药厂有限公司 | 国药准字H20093299 | 10ml:5g | Category B (乙) | XA06ADR050X001030201123 | NHSA |
| Fresenius Kabi Austria GmbH | 国药准字HJ20170152 | 15ml:10g | Category B (乙) | XA06ADR050X001030278433 | NHSA |
| Abbott B.V. | 国药准字HJ20171057 | 667mg/ml | Category B (乙) | XA06ADR050X001030278890 | NHSA |
| 北京麦康药业有限公司 | 国药准字H20234273 | 15ml:10g | Category B (乙) | XA06ADR050X001030280528 | NHSA |
| 江西丹康制药有限公司 | 国药准字H20244824 | 15ml:10g | Category B (乙) | XA06ADR050X001030284227 | NHSA |
| 大连美罗中药厂有限公司 | 国药准字H20093299 | 10ml:5g | Category B (乙) | XA06ADR050X001030301123 | NHSA |
| 北京麦康药业有限公司 | 国药准字H20234273 | 15ml:10g | Category B (乙) | XA06ADR050X001030380528 | NHSA |
| 江西丹康制药有限公司 | 国药准字H20244824 | 15ml:10g | Category B (乙) | XA06ADR050X001030384227 | NHSA |
| 大连美罗中药厂有限公司 | 国药准字H20093299 | 10ml:5g | Category B (乙) | XA06ADR050X001030401123 | NHSA |
| 大连美罗中药厂有限公司 | 国药准字H20093299 | 10ml:5g | Category B (乙) | XA06ADR050X001030501123 | NHSA |
| 大连美罗中药厂有限公司 | 国药准字H20093299 | 10ml:5g | Category B (乙) | XA06ADR050X001030601123 | NHSA |
| 北京韩美药品有限公司 | 国药准字H20065730 | 100ml:66.7g | Category B (乙) | XA06ADR050X001040100041 | NHSA |
| 大连美罗中药厂有限公司 | 国药准字H20093300 | 100ml:50g | Category B (乙) | XA06ADR050X001040101123 | NHSA |
| Fresenius Kabi Austria GmbH | 国药准字HJ20170248 | 100ml:67g | Category B (乙) | XA06ADR050X001040178433 | NHSA |
| 福元药业有限公司 | 国药准字H20243601 | 15ml:10g | Category B (乙) | XA06ADR050X001040180651 | NHSA |
| Fresenius Kabi Austria GmbH | 国药准字HJ20160470 | 100ml:67g | Category B (乙) | XA06ADR050X001050178433 | NHSA |
| Fresenius Kabi Austria GmbH | 国药准字HJ20160470 | 100ml:67g | Category B (乙) | XA06ADR050X001050278433 | NHSA |
| 福建省融恒医药有限公司 | 国药准字H20264457 | 15ml:10g | Category B (乙) | XA06ADR050X001020184977 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 36 filings and 25 distinct first applicants.
Supplement 7 · Generic 29
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 湖南科伦制药有限公司 | CYHB2600092 | Supplement | 2026/01/17 | Not stated by source | CDE |
| 山东鲁抗三叶制药有限公司;莱阳市江波制药有限责任公司 | CYHS2600520 | Generic | 2026/02/25 | Not stated by source | CDE |
| 石家庄凯达生物工程有限公司;乐声药业石家庄有限公司 | CYHS2602064 | Generic | 2026/08/20 | Not stated by source | CDE |
| 石家庄凯达生物工程有限公司;乐声药业石家庄有限公司 | CYHS2602063 | Generic | 2026/08/20 | Not stated by source | CDE |
| 江苏悦兴药业有限公司 | CYHB2501371 | Supplement | 2025/07/10 | Not stated by source | CDE |
| 江苏神华药业有限公司 | CYHS2504208 | Generic | 2025/12/06 | Not stated by source | CDE |
| 江苏晨牌邦德药业有限公司 | CYHS2504268 | Generic | 2025/12/12 | Not stated by source | CDE |
| 海南斯达制药有限公司 | CYHB2601906 | Supplement | 2026/10/19 | Not stated by source | CDE |
| 海南斯达制药有限公司 | CYHB2601905 | Supplement | 2026/10/19 | Not stated by source | CDE |
| 成都普什制药有限公司 | CYHS2602265 | Generic | 2026/09/10 | Not stated by source | CDE |
| 河北华晨药业集团有限公司 | CYHS2602186 | Generic | 2026/09/02 | Not stated by source | CDE |
| 河北华晨药业集团有限公司 | CYHS2602185 | Generic | 2026/09/02 | Not stated by source | CDE |
| 江西丹康制药有限公司 | CYHB2601564 | Supplement | 2026/08/17 | Not stated by source | CDE |
| 浙江国镜药业有限公司 | CYHS2601987 | Generic | 2026/08/13 | Not stated by source | CDE |
| 江西施美药业股份有限公司 | CYHS2601959 | Generic | 2026/08/10 | Not stated by source | CDE |
| 浙江美迪深生物医药有限公司;浙江凯润药业股份有限公司 | CYHS2601547 | Generic | 2026/07/01 | Not stated by source | CDE |
| 浙江美迪深生物医药有限公司;浙江凯润药业股份有限公司 | CYHS2601546 | Generic | 2026/07/01 | Not stated by source | CDE |
| 湖北美思创药业有限公司 | CYHB2601115 | Supplement | 2026/06/12 | Not stated by source | CDE |
| 湖北美思创药业有限公司 | CYHB2601108 | Supplement | 2026/06/12 | Not stated by source | CDE |
| 河南羚锐制药股份有限公司 | CYHS2600646 | Generic | 2026/03/12 | Not stated by source | CDE |
| 浙江金立源药业有限公司 | CYHS2600322 | Generic | 2026/01/31 | Not stated by source | CDE |
| 江西迪赛诺医药集团有限公司;赤峰源生药业有限公司 | CYHS2504252 | Generic | 2025/12/11 | Not stated by source | CDE |
| 江西迪赛诺医药集团有限公司;赤峰源生药业有限公司 | CYHS2504251 | Generic | 2025/12/11 | Not stated by source | CDE |
| 江西迪赛诺医药集团有限公司;赤峰源生药业有限公司 | CYHS2504250 | Generic | 2025/12/11 | Not stated by source | CDE |
| 江西药都仁和制药有限公司 | CYHS2503984 | Generic | 2025/11/18 | Not stated by source | CDE |
| 天津和治药业集团有限公司 | CYHS2503347 | Generic | 2025/09/10 | Not stated by source | CDE |
| 天津和治药业集团有限公司 | CYHS2503346 | Generic | 2025/09/10 | Not stated by source | CDE |
| 浙江震元制药有限公司 | CYHS2502985 | Generic | 2025/08/15 | Not stated by source | CDE |
| 浙江震元制药有限公司 | CYHS2502984 | Generic | 2025/08/15 | Not stated by source | CDE |
| 浙江震元制药有限公司 | CYHS2502982 | Generic | 2025/08/15 | Not stated by source | CDE |
| 浙江康恩贝制药股份有限公司 | CYHS2502896 | Generic | 2025/08/09 | Not stated by source | CDE |
| 浙江康恩贝制药股份有限公司 | CYHS2502895 | Generic | 2025/08/09 | Not stated by source | CDE |
| 武汉安成医药有限责任公司;湖北济安堂药业股份有限公司 | CYHS2501838 | Generic | 2025/05/22 | Not stated by source | CDE |
| 北京金典汉方药业股份有限公司 | CYHS2501558 | Generic | 2025/04/25 | Not stated by source | CDE |
| 河南泰丰生物科技有限公司 | CYHS2501451 | Generic | 2025/04/16 | Not stated by source | CDE |
| 湖北午时药业股份有限公司 | CYHS2501168 | Generic | 2025/03/25 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 12 filings and 9 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 山东鲁抗三叶制药有限公司;莱阳市江波制药有限责任公司 | CYHS2600520 | Generic | 2026/02/25 | Not stated by source | CDE |
| 石家庄凯达生物工程有限公司;乐声药业石家庄有限公司 | CYHS2602064 | Generic | 2026/08/20 | Not stated by source | CDE |
| 石家庄凯达生物工程有限公司;乐声药业石家庄有限公司 | CYHS2602063 | Generic | 2026/08/20 | Not stated by source | CDE |
| 成都普什制药有限公司 | CYHS2602265 | Generic | 2026/09/10 | Not stated by source | CDE |
| 河北华晨药业集团有限公司 | CYHS2602186 | Generic | 2026/09/02 | Not stated by source | CDE |
| 河北华晨药业集团有限公司 | CYHS2602185 | Generic | 2026/09/02 | Not stated by source | CDE |
| 浙江国镜药业有限公司 | CYHS2601987 | Generic | 2026/08/13 | Not stated by source | CDE |
| 江西施美药业股份有限公司 | CYHS2601959 | Generic | 2026/08/10 | Not stated by source | CDE |
| 浙江美迪深生物医药有限公司;浙江凯润药业股份有限公司 | CYHS2601547 | Generic | 2026/07/01 | Not stated by source | CDE |
| 浙江美迪深生物医药有限公司;浙江凯润药业股份有限公司 | CYHS2601546 | Generic | 2026/07/01 | Not stated by source | CDE |
| 河南羚锐制药股份有限公司 | CYHS2600646 | Generic | 2026/03/12 | Not stated by source | CDE |
| 浙江金立源药业有限公司 | CYHS2600322 | Generic | 2026/01/31 | Not stated by source | CDE |
API registrations
Non-component matches: 1 companies with A status and 0 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 乳果糖 | Fresenius Kabi Austria GmbH | Y20170001096 | A | Exact ingredient | 2025/10/15 | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/10 07:23. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
-
2026/11/09Supplement delivery
江西丹康制药有限公司
CYHB2601564
Fact date: 2026/11/09 · Publication date: 2026/11/10 · Site observation date: 2026/11/10
Supplemental application; excluded from new marketing approvals.
View source · Table row 20 ↗ -
2026/11/09Supplement delivery
湖南科伦制药有限公司
CYHB2600092
Fact date: 2026/11/09 · Publication date: 2026/11/10 · Site observation date: 2026/11/10
Supplemental application; excluded from new marketing approvals.
View source · Table row 10 ↗ -
2026/11/07No longer listed under review
亚邦医药股份有限公司;陕西汉唐制药有限公司
CYHB2601876
Fact date: 2026/11/07 · Site observation date: 2026/11/07
Accepted: 2026/10/13
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/11/06 (approval no.: —; approval date: 2026/11/05); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 34
NMPA · Table row 34 ↗ View source ↗ -
2026/11/07No longer listed under review
亚邦医药股份有限公司;陕西汉唐制药有限公司
CYHB2601875
Fact date: 2026/11/07 · Site observation date: 2026/11/07
Accepted: 2026/10/13
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/11/06 (approval no.: —; approval date: 2026/11/05); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 33
NMPA · Table row 33 ↗ View source ↗ -
2026/11/07No longer listed under review
亚邦医药股份有限公司;陕西汉唐制药有限公司
CYHB2601874
Fact date: 2026/11/07 · Site observation date: 2026/11/07
Accepted: 2026/10/13
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/11/06 (approval no.: —; approval date: 2026/11/05); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 32
NMPA · Table row 32 ↗ View source ↗ -
2026/11/07No longer listed under review
亚邦医药股份有限公司;陕西汉唐制药有限公司
CYHB2601873
Fact date: 2026/11/07 · Site observation date: 2026/11/07
Accepted: 2026/10/13
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/11/06 (approval no.: —; approval date: 2026/11/05); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 31
NMPA · Table row 31 ↗ View source ↗ -
2026/11/05Supplement delivery
亚邦医药股份有限公司
CYHB2601876
Fact date: 2026/11/05 · Publication date: 2026/11/06 · Site observation date: 2026/11/06
Supplemental application; excluded from new marketing approvals.
View source · Table row 34 ↗ -
2026/11/05Supplement delivery
亚邦医药股份有限公司
CYHB2601875
Fact date: 2026/11/05 · Publication date: 2026/11/06 · Site observation date: 2026/11/06
Supplemental application; excluded from new marketing approvals.
View source · Table row 33 ↗ -
2026/11/05Supplement delivery
亚邦医药股份有限公司
CYHB2601874
Fact date: 2026/11/05 · Publication date: 2026/11/06 · Site observation date: 2026/11/06
Supplemental application; excluded from new marketing approvals.
View source · Table row 32 ↗ -
2026/11/05Supplement delivery
亚邦医药股份有限公司
CYHB2601873
Fact date: 2026/11/05 · Publication date: 2026/11/06 · Site observation date: 2026/11/06
Supplemental application; excluded from new marketing approvals.
View source · Table row 31 ↗ -
2026/10/19Accepted
-
2026/10/19Accepted
-
2026/10/13Accepted
亚邦医药股份有限公司;陕西汉唐制药有限公司
CYHB2601876
Fact date: 2026/10/13 · Site observation date: 2026/10/22
View source ↗ -
2026/10/13Accepted
亚邦医药股份有限公司;陕西汉唐制药有限公司
CYHB2601875
Fact date: 2026/10/13 · Site observation date: 2026/10/22
View source ↗ -
2026/10/13Accepted
亚邦医药股份有限公司;陕西汉唐制药有限公司
CYHB2601874
Fact date: 2026/10/13 · Site observation date: 2026/10/22
View source ↗ -
2026/10/13Accepted
亚邦医药股份有限公司;陕西汉唐制药有限公司
CYHB2601873
Fact date: 2026/10/13 · Site observation date: 2026/10/22
View source ↗ -
2026/09/17Accepted
联环药业（安庆）有限公司;江苏联环药业股份有限公司
CYHB2601757
Fact date: 2026/09/17 · Site observation date: 2026/10/21
View source ↗ -
2026/09/17Accepted
联环药业（安庆）有限公司;江苏联环药业股份有限公司
CYHB2601756
Fact date: 2026/09/17 · Site observation date: 2026/10/21
View source ↗ -
2026/09/10Accepted
-
2026/09/02Accepted
-
2026/09/02Accepted
-
2026/08/20Accepted
石家庄凯达生物工程有限公司;乐声药业石家庄有限公司
CYHS2602064
Fact date: 2026/08/20 · Site observation date: 2026/10/21
View source ↗ -
2026/08/20Accepted
石家庄凯达生物工程有限公司;乐声药业石家庄有限公司
CYHS2602063
Fact date: 2026/08/20 · Site observation date: 2026/10/21
View source ↗ -
2026/08/17Accepted
-
2026/08/13Accepted
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/10 07:27
- Chemical-drug catalogue
- Last successful update: 2026/11/10 07:23
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/10 07:25
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31
First index-page publication dates: 2026-10-26 to 2026-11-10; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/10 08:10 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 3/30; discovered pending details: 20. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Lactulose Oral Solution
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Yearly
US$1,920
Billed every year
US$160 per month
Online subscriptions are not enabled. The form below registers interest; it does not charge or activate access.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
US$490
One payment · 12 months of access
Online comparison-table purchase is not enabled.
Billed by Creem, our merchant of record · Terms · Refund policy